The largest database of trusted experimental protocols

Glomax explorer

Manufactured by Promega
Sourced in United States, Italy, Germany, Sweden

The GloMax Explorer is a multi-mode microplate reader designed for a variety of laboratory applications. It offers luminescence, fluorescence, and absorbance detection capabilities in a compact and user-friendly format.

Automatically generated - may contain errors

148 protocols using glomax explorer

1

Quantification of Plasma Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
D-dimer levels in sodium citrate plasma samples were measured via an enzyme-linked immunosorbent assay (ELISA) (Ray Biotech, Peachtree Corners, GA) per the manufacturer’s protocol. Samples were diluted 600,000-fold and plated in duplicate. IL-4 levels in plasma samples were measured using a Monkey IL-4 ELISA kit (abcam, Boston, MA) per the manufacturer’s protocol. Plasma samples were diluted 1:2 and assayed in duplicate along with two replicates of undiluted sample. In modification to the manufacturer’s protocol, the standard/sample incubation time was increased to 2.5 hours. Plates were analyzed using the GloMax Explorer plate reader (Promega, Madison, WI) and GraphPad Prism (GraphPad Software version 9, LaJolla, California). Heatmap was generated using Microsoft Excel. Data was normalized by dividing raw data values from Day 4, (D-dimer only) 6, 14 and 21 by the baseline value for each animal.
Kynurenine and tryptophan levels in plasma were measured using commercially available enzyme-linked immunosorbent assays (Rocky Mountain Diagnostics, Colorado Springs, CO) per the manufacturer’s protocol. The GloMax Explorer plate reader (Promega, Madison, WI) along with GraphPad Prism v9 were used to analyze the plates.
+ Open protocol
+ Expand
2

Viral infection and inhibition assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated at a density of 2.5 × 104 cells per well in a 96-well plate, the day before infection. Cells were infected with CHIKV-Nluc, rVSVΔG-LASV-NlucP, or Coxsackie B5 at an MOI of 0.05. Two hours post-infection, cells were treated with 10 mM ammonium chloride (NH4Cl) to inhibit subsequent rounds of replication. Eight hours after infection, cells infected with CHIKV or rVSVΔG-LASV were lysed with NanoGlo substrate, and lysates were quantified in a GloMax Explorer (Promega) according to the manufacturer’s instructions. Cells infected with Coxsackie B5 were harvested 24 h post-infection and cell viability was assessed using Cell Titer Glo and quantified in a GloMax Explorer (Promega) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
3

HEK293 Cell Luciferase Reporter Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293 cells were seeded in 24-well plates at 70–80% confluency. In total, 200 ng/well of firefly luciferase-encoding reporter plasmids, 500 ng/well of dLwCas13a-NF and gRNA (gene-specific or nontargeting) were transfected using Lipofectamine 2000. Ten ng/well of Renilla luciferase was used as transfection control. Firefly and Renilla luciferase activities were measured using Dual-Luciferase Reporter Assay System (Promega) using GloMax Explorer (Promega) 24 h post transfection in case of samples involving VEGFA and MTCH2, and 48 h post transfection in case of AGO1.
For in vitro induction of SCR, the AGO1-Luciferase reporter construct was linearized using NotI restriction enzyme. Following this, the purified linearized plasmid was subjected to in vitro transcription using T7 RNA polymerase for 3 h at 37 °C. The RNA was purified, and the quality and concentration were determined using BioPhotometer (Eppendorf). The luciferase reporter RNA (500 ng) was in vitro translated using Rabbit Reticulocyte Lysate (Promega) in the presence of 4 µg cell extract (prepared as described under “Luminescence-based ribosomal pausing assay”) and RNase inhibitor for 90 min. Luminescence was measured using the Luciferase Assay System (Promega) in the GloMax Explorer (Promega).
+ Open protocol
+ Expand
4

Biofilm Formation and Quantification in C. difficile

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate biofilms, we diluted overnight cultures of C. difficile 1:100 into fresh BHISG, deposited 1 ml per well in 24-well polystyrene tissue culture–treated plates (Falcon, USA), and incubated the plates at 37°C in anaerobic environment for 24 hours. Biofilm biomass was measured using a crystal violet as described elsewhere (79 (link)). Briefly, spent media were removed by inversion, and wells were washed twice with phosphate-buffered saline (PBS), dried, stained with crystal violet for 2 min, and washed twice again with PBS. Crystal violet was solubilized with a 75% ethanol solution, and the OD600 was measured with a plate reader (Promega GloMax Explorer, Promega, France).
+ Open protocol
+ Expand
5

SARS-CoV-2 Pseudovirus Neutralization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 pseudovirus neutralization assay was performed as previously described [14 (link)]. Briefly, hACE2-expressing cells, hACE2-293T, were seeded onto 96-well plates 18 h before infection. mAbs were serially diluted and co-incubated with the same volume of pseudotype particles at 37 °C for 1 h. MEM was added as the negative control. The mixtures were added to the monolayers of hACE2-293T. Next, the plates were incubated at 37 °C in 5% CO2. Forty-eight hours later, the cells were lysed and analyzed using Promega GloMax Explorer (Promega, Madison, USA). Inhibition rates of mAbs at different dilutions were calculated and compared to those of the negative control. Anti-SARS-CoV-2-RBD mouse serum samples were used as the positive control, and mouse anti-PBS serum samples were used as the negative control. For each experiment, the positive convalescent serum from a patient with COVID-19 was used as a standard experimental control.
+ Open protocol
+ Expand
6

Measuring Redox State in Botrytis cinerea

Check if the same lab product or an alternative is used in the 5 most similar protocols
Redox state of roGFP transformed B. cinerea was measured in liquid culture using a fluorimeter. B. cinerea strains expressing GRX-roGFP and mito-roGFP were grown for 2 weeks on PDA medium at 18°C in the light to induce mass sporulation. A total of 10 mL of PDB medium containing 100 μM CK was inoculated with conidia and incubated for 24 h at 18°C, with 150 rpm shaking. Samples of 1 mL were taken and washed twice in double-distilled water, and 200 μL of the washed germlings were transferred to a 96-well plate (Microplate pureGrade 96-well PS, transparent bottom) for fluorescence measurements using a fluorimeter (Promega GloMax explorer multimode microplate reader, GM3500, USA). Fluorescence was measured at the bottom with 3 × 3 reads/well and an excitation wavelength of 405 ± 5 nm for the oxidized state and 488 ± 5 nm for the reduced state of roGFP2. The emission was detected at 510 ± 5 nm (52 (link)). The gain was set to 100. Relative fluorescence units (RFU) were recorded to calculate the Em405/Em488 ratio.
+ Open protocol
+ Expand
7

Cell-Cell Spread of VSV-G Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell-to-cell spread of VSV-G in Vero cells was determined using Endurazine substrate (Promega, Madison, WI, USA) following manufacturer’s specifications. Vero cells were plated in a black-walled, clear-bottom 96-well plate at a density of 3 × 105 cells/mL with DMEM 5% FBS. Once attached to the plate, cells were starved from lipids by replacing the media with serum-free DMEM. After 20 h, media were substituted with DMEM 5% Lipoprotein Depleted FBS (Cat #880100-1, Kalen Biomedical LLC, Germantown, MD, USA). Cells were infected with 50 µL of VSV-G-nLuciPest at an MOI of 0.04 using serum-free DMEM. One hour after infection, media were removed and replaced with 200µL of phenol red-free DMEM supplemented with 5% Lipoprotein Depleted FBS, 25 mM HEPES, 1:200 Endurazine and treated with LysoPC 16:0 (SKU #855675P, Avanti Polar Lipids, Birmingham, AL, USA) or 18:1 (SKU #845875P, Avanti Polar Lipids, Birmingham, AL, USA) 0.5 µM or 5 µM. The plate was moved into a pre-warmed (37 °C) GloMax Explorer (Promega, Madison, WI, USA), and luminescence was measured every 10 min for a period of 24 h.
+ Open protocol
+ Expand
8

Cloning and Evaluating IL-1β 3'UTR

Check if the same lab product or an alternative is used in the 5 most similar protocols
The UTR sequences of human IL-1β, including the XhoI (forward) and XbaI (reverse) endonuclease sites at both ends, were purchased from Integrated DNA Technologies (IDT, Republic of Singapore). The 3′ UTR fragment was then cloned into the pMIR GLO vector (Promega Corporation, Fitchburg, WI, USA). HeLa cells were plated at a density of 1 × 105 cells/well in a 12-well plate and then transfected with either pMIR GLO control vector or pMIR GLO vector with IL-1β 3′ UTR using Lipofectamine 2000 (Thermo Fisher Scientific). Two days after the transfection, the luciferase activity of the cells was measured using a luminometer and Dual Luciferase Assay Kit (Promega Corporation) according to the manufacturer’s instructions. Cell number and transfection efficiency were normalized with Renilla luciferase assay. Luciferase intensity was determined using the Glomax® Explorer multimode microplate reader (Promega, WI, USA).
+ Open protocol
+ Expand
9

Neutralizing Clostridium Difficile Toxins

Check if the same lab product or an alternative is used in the 5 most similar protocols
When almost reaching confluence, cells were treated with 7.5 ng/mL TcdA, 100 ng/mL TcdB, or a combination of both. The applied toxin concentrations were predetermined as the respective IC50. The neutralisation assay was carried out by pre-incubating TcdA and TcdB with 50 µg/mL monoclonal antibody bezlotoxumab (Merck, Darmstadt, Germany), monoclonal recombinant sIgA, or sIgA isolated from goat whey for 2 h at 37 °C prior to cell treatment. Used concentrations equalled to a 14,000-fold and 930-fold molar excess of bezlotoxumab and a 5300-fold and 350-fold molar excess of sIgA to TcdA and TcdB, respectively. After 24 h, cells were fixed and subjected to sulforhodamine B (SRB) cytotoxicity assays [54 (link)]. In brief, cells were fixed with 10% trichloroacetic acid (TCA) for one hour at 4 °C and then rinsed with tap water four times. After air-drying, cells were stained with 0.057% SRB in 1% acetic acid for 30 min. Subsequently, cells were rinsed with 1% acetic acid four times to remove excess SRB before air-drying again. Cell-bound dye was then solubilised in 10 mM TRIS and extinction was measured at 488 nm using a fluoro spectrometer (Glomax® Explorer, Promega, Vienna, Austria).
+ Open protocol
+ Expand
10

Cisplatin and Biochanin A Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, 3000 cells/well were plated into 96-well, grown for overnight, treated with cisplatin (8 µM) and/or Biochanin A (100 µM) for the indicated time points, followed by incubation with cell counting kit-8 (CCK-8) substrate (Dojindo) for 1 h at 37 °C. The absorbance was examined at 450 nm by the GloMax Explorer (Promega).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!